Showing results (301-310 of 1,519) with videos related to

Sort By:
Pageof 152
Journal of Neonatal-Perinatal Medicine|August 29, 2018
Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit populationE Chung, S E Lee, T Abraham, et al.
European Journal of Heart Failure|September 21, 2016
Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trialMelissa Martinson, Rupinder Bharmi, Nirav Dalal, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2003
Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failureDaniel A Lewis, Nandkishore R Gurram, William T Abraham, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|March 15, 2021
Opioid Prescribing Practices in Cleft Lip and Cleft Palate ReconstructionReuben A Falola, Jordan T Blough, Jasson T Abraham, et al.
General Pharmacology|September 1, 1997
Extraneuronal uptake inhibitor U-0521 decreases contractile responses in rat vas deferensP J Rice, S T Abraham, N Y Huang, et al.
Kidney International|April 12, 2000
Therapy of heart failureR W Schrier, J G Abdallah, H H Weinberger, et al.
European Journal of Biochemistry|March 7, 2001
Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinasesA Livolsi, V Busuttil, V Imbert, et al.
Oncology Reports|May 25, 2011
Immunoregulation of T-lymphocytes by autologous serum in oral-cancerG Meenattoor, P Balaram, N Hareendran, et al.
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failureDavid S Feldman, Cynthia A Carnes, William T Abraham, et al.
Pageof 152